The effect of ANX005, an anti-C1Q antibody, on biomarkers of target and pathway engagement and neurodegeneration in ALS patients
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110398
- Recipient
-
Annexon, Inc. UEI KVPFLBUEA8C7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $143,840
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$98,872 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $540 | |
| Original award | $242,172 |
Quick answers
Who received award W81XWH2110398?
W81XWH2110398 was awarded to Annexon, Inc. by Defense Health Agency (Department of Defense) on June 1, 2021.
How much is award W81XWH2110398 worth?
$143,840 has been obligated on W81XWH2110398.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award